V-Bio Ventures invests in RootWave in a EUR 6.5 m Series A financing to develop and market electrical weed killing solutions v-bio-ventures2020-04-24T08:38:22+02:00February 7th, 2020|V-Bio News| Read More
V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases v-bio-ventures2020-04-24T08:38:22+02:00December 16th, 2019|V-Bio News| Read More
V-Bio Ventures leads AgomAb Therapeutics’ Euros 21m Series A Financing v-bio-ventures2020-04-24T08:38:23+02:00April 3rd, 2019|V-Bio News| Read More
V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals v-bio-ventures2020-04-24T08:38:23+02:00November 15th, 2018|V-Bio News| Read More
V-Bio Ventures participates in 22.5 million euros series B financing round of HORAMA v-bio-ventures2020-04-24T08:38:23+02:00September 18th, 2018|V-Bio News| Read More
V-Bio Ventures invests in UCB spinout Syndesi Therapeutics to develop novel therapeutics for cognitive disorders v-bio-ventures2020-04-24T08:38:23+02:00February 1st, 2018|V-Bio News| Read More
V-Bio Ventures leads EUR 7.7M financing of Aphea.Bio v-bio-ventures2020-04-24T08:38:24+02:00June 16th, 2017|V-Bio News| Read More
V-Bio Ventures invests in OCTIMET Oncology v-bio-ventures2020-04-24T08:38:24+02:00January 19th, 2017|V-Bio News| Read More
V-Bio Ventures closes first life sciences fund, raising over € 75 million v-bio-ventures2020-04-24T08:38:24+02:00December 1st, 2016|V-Bio News| Read More
V-Bio Ventures invests in VIB spinout Confo Therapeutics NV v-bio-ventures2020-04-24T08:38:25+02:00February 2nd, 2016|V-Bio News| Read More
First Closing of V-Bio Ventures Fund 1 with commitments of € 63 million v-bio-ventures2020-04-24T08:38:25+02:00November 19th, 2015|V-Bio News| Read More
